ICURE PROPOSES THE INTEGRATED USE OF PRE-CLINICAL TOOLS AND CLINICAL TOOLS IN ORDER TO DEVELOP A GLOBAL QUANTITATIVE ARCHITECTURE OF THE PROTECTION OF THE COLON (CRC) IN THE FIELD, WHICH IDENTIFIES SPECIFIC PRIMARY CANCER DEPENDING ON THE CELLULAR TYPE AND THE PATHWAYS SPECIFIC TO TURMOGENICI, WHICH CONTRIBUTE TO THE TURMOENESI. IN ADDITION, THE MOLECULAR DETAILS WILL BE EXPLAINED THROUGH WHICH A GENOTYPE LEADS TO THE ACTIVATION OF DOWNSTREAM GENES DRIVING THE UNCONTROLLED GROWTH OF CELLULES.THIS MODEL WILL BE USED TO FIND NEW THERAPEUTIC TARGETS, TO GUIDE GENETIC AND EPIGENETIC SCREENINGS, TO IDENTIFY THOSE WITH A HIGH RISK OF DEVELOPING CRC, AND TO CLASSIFY PATIENTS IN MOLECULAR SUBGROUPS IN ORDER TO SELECT THE TREATMENT (OR COMBINATION OF TREATMENTS), WHICH MAY BE OPTIMAL FOR EACH PATIENT (PERSONALISED MEDICINE).